Lightstone and Takeda lead USD35m financing of Cerevance
A cross-border team from law firm Goodwin represented the neuroscience company Cerevance in its financing by Lightstone Ventures and Takeda Pharmaceutical. Cerevance will focus on discovering and developing novel therapeutics for neurological and psychiatric disorders. The USD36 million funding round includes a USD21.5 million Series A financing investment from

